Cargando…

HER2 Oncogene Amplification and Immunohistochemical Profiling in Gastric Adenocarcinoma

Background and Objectives: Gastric adenocarcinoma is one of the most common malignant tumors and a major cause of cancer death worldwide, especially in developing countries. Her2/neu gene amplification and protein overexpression in breast cancer is a golden criterion for the targeted therapy with tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raj, Nisha, Verma, Divya, Kumar, Ashok, Rai, Praveer, Rao, Ram Nawal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Applied Systems srl 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086066/ https://www.ncbi.nlm.nih.gov/pubmed/32309603 http://dx.doi.org/10.15190/d.2018.6

Ejemplares similares

Ampullary Neuroendocrine Tumor Presenting with Biliary Obstruction and Gastric Outlet Obstruction
por: Rai, Praveer, et al.
Publicado: (2012)

Cytologic Categorization with Risk Stratification of Endoscopic Ultrasound-Guided Fine Needle Aspiration from Pancreatic Lesions Based on Guidelines of the Papanicolaou Society of Cytopathology: 12-Year Tertiary Care Experience
por: Nishith, Nilay, et al.
Publicado: (2021)

HER-2/neu oncogene: what does amplification mean?
por: Pavy, J. J., et al.
Publicado: (1993)

Her2/neu Protein Expression and Oncogene Amplification in Gastric Carcinoma with Clinico-Pathological Correlation in Egyptian Patients
por: Hadi, Ahmed Abdel, et al.
Publicado: (2016)

HER-2/neu Marker Examination using Immunohistochemical Method in Patients Suffering from Gastric Adenocarcinoma
por: Movagharnejad, Kourosh, et al.
Publicado: (2013)

Oncogenic HER2 fusions in gastric cancer
por: Yu, De-Hua, et al.
Publicado: (2015)

Gall Bladder Carcinoma with Ampullary Carcinoma: A Rare Case of Double Malignancy
por: Rai, Praveer, et al.
Publicado: (2013)

Working together for the family: determination of HER oncogene co-amplifications in breast cancer
por: Laurito, Sergio, et al.
Publicado: (2020)

Significance of HER2 protein expression and HER2 gene amplification in colorectal adenocarcinomas
por: Wang, Xin-Yu, et al.
Publicado: (2019)

Immunohistochemical Profile for Unknown Primary Adenocarcinoma
por: Hashimoto, Kenji, et al.
Publicado: (2012)

Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors
por: Marotta, Michael, et al.
Publicado: (2017)

HER2 gene amplification in esophageal squamous cell carcinoma is less than in gastroesophageal junction and gastric adenocarcinoma
por: HUANG, JUN-XING, et al.
Publicado: (2013)

Composite pheochromocytoma-ganglioneuroma of the adrenal gland: A case report with immunohistochemical study
por: Rao, Ram Nawal, et al.
Publicado: (2013)

Giant Fungal Gastric Ulcer in an Immunocompetent Individual
por: Rai, Praveer, et al.
Publicado: (2012)

Peripheral position of CCND1 and HER-2/neu oncogenes within chromosome territories in esophageal and gastric cancers non-related to amplification and overexpression
por: Bizari, Lucimari, et al.
Publicado: (2009)

Oncogenic EFNA4 Amplification Promotes Lung Adenocarcinoma Lymph Node Metastasis
por: Zhao, Xiangyu, et al.
Publicado: (2022)

Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification
por: Oh, Doo-Yi, et al.
Publicado: (2017)

HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing
por: Rüschoff, Josef, et al.
Publicado: (2010)

Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses
por: Blancato, J, et al.
Publicado: (2004)

Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study
por: Ordás, Javier, et al.
Publicado: (2007)

Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
por: Reis-Filho, Jorge S, et al.
Publicado: (2005)

Techniques of imaging of nodal stations of gastric cancer by endoscopic ultrasound
por: Sharma, Malay, et al.
Publicado: (2014)

Oncogene Amplification in Squamous Cell Carcinoma of the Oral Cavity
por: Saranath, Dhananjaya, et al.
Publicado: (1989)

Low frequency of HER2 amplification and overexpression in early onset gastric cancer
por: Moelans, Cathy B., et al.
Publicado: (2011)

Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer
por: Stahl, Phillip, et al.
Publicado: (2015)

TOPOIIα and HER-2/neu overexpression/amplification in Barrett’s oesophagus, dysplasia and adenocarcinoma
por: Rossi, Elisa, et al.
Publicado: (2010)

An analysis of HER2 amplification in cervical adenocarcinoma: correlation with clinical outcomes and the International Endocervical Adenocarcinoma Criteria and Classification
por: Shi, Haiyan, et al.
Publicado: (2020)

An immunohistochemical study of thioredoxin domain-containing 5 expression in gastric adenocarcinoma
por: WU, ZHIMING, et al.
Publicado: (2015)

Asian EUS Cup-06: Diagnosis and treatment of recurrent upper gastrointestinal bleed with endoscopic ultrasound (gastric varix with splenic artery aneurysm)
por: Rai, Praveer, et al.
Publicado: (2017)

Immunohistochemical analysis of RTKs expression identified HER3 as a prognostic indicator of gastric cancer
por: Ema, Akira, et al.
Publicado: (2014)

Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer
por: Scheel, Andreas H., et al.
Publicado: (2018)

Amplification of c-erbB-2 proto-oncogene in cancer foci, adjacent normal, metastatic and normal tissues of human primary gastric adenocarcinomas.
por: Kim, J. S., et al.
Publicado: (1997)

Immunohistochemical profiles of claudin-3 in primary and metastatic prostatic adenocarcinoma
por: Bartholow, Tanner L, et al.
Publicado: (2011)

PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer
por: Kim, Chan, et al.
Publicado: (2017)

Dosage amplification dictates oncogenic regulation by the NKX2-1 lineage factor in lung adenocarcinoma
por: Pulice, John L., et al.
Publicado: (2023)

Amplification of KRAS and its heterogeneity in non-Asian gastric adenocarcinomas
por: Rehkaemper, Jan, et al.
Publicado: (2020)

Her2+ and b-HCG Producing Undifferentiated Gastric Adenocarcinoma
por: Eivaz-Mohammadi, Sahar, et al.
Publicado: (2014)

LED-FISH: Fluorescence microscopy based on light emitting diodes for the molecular analysis of Her-2/neu oncogene amplification
por: Lang, Dagmar S, et al.
Publicado: (2008)

Nasojejunal tube‐assisted endoscopic ultrasound‐guided gastrojejunostomy for the management of gastric outlet obstruction is safe and effective
por: Rai, Praveer, et al.
Publicado: (2023)

Amplification of Cellular Oncogenes in Solid Tumors
por: Bagci, Ozkan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uvesdqp9bpeapho90vu36v9r18